Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Taiana

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Oncotarget|September 27, 2017
Long non-coding RNAs in B-cell malignancies: a comprehensive overviewLucia Nobili, Domenica Ronchetti, Elisa Taiana, et al.
Genes|February 2, 2018
Long Non-Coding RNAs in Multiple MyelomaLucia Nobili, Domenica Ronchetti, Luca Agnelli, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2021
Bioinformatics Pipeline to Analyze lncRNA ArraysKatia Todoerti, Domenica Ronchetti, Martina Manzoni, et al.
Non-Coding RNA|July 8, 2020
LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems?Elisa Taiana, Domenica Ronchetti, Katia Todoerti, et al.
Cancer Gene Therapy|March 17, 2024
The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancersDomenica Ronchetti, Valentina Traini, Ilaria Silvestris, et al.
Scientific Reports|April 28, 2018
A compendium of long non-coding RNAs transcriptional fingerprint in multiple myelomaDomenica Ronchetti, Luca Agnelli, Alessandro Pietrelli, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2021
CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA NetworkEugenio Morelli, Annamaria Gulla', Nicola Amodio, et al.
Haematologica|May 6, 2021
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcomeKatia Todoerti, Domenica Ronchetti, Vanessa Favasuli, et al.
Cancers|April 3, 2021
The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple MyelomaTina Paradzik, Cecilia Bandini, Elisabetta Mereu, et al.
Cancer Letters|May 17, 2015
The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracilMarzia B Gariboldi, Elisa Taiana, Maria Chiara Bonzi, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Oncotarget|September 27, 2017
Long non-coding RNAs in B-cell malignancies: a comprehensive overviewLucia Nobili, Domenica Ronchetti, Elisa Taiana, et al.
Genes|February 2, 2018
Long Non-Coding RNAs in Multiple MyelomaLucia Nobili, Domenica Ronchetti, Luca Agnelli, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2021
Bioinformatics Pipeline to Analyze lncRNA ArraysKatia Todoerti, Domenica Ronchetti, Martina Manzoni, et al.
Non-Coding RNA|July 8, 2020
LncRNA NEAT1 in Paraspeckles: A Structural Scaffold for Cellular DNA Damage Response Systems?Elisa Taiana, Domenica Ronchetti, Katia Todoerti, et al.
Cancer Gene Therapy|March 17, 2024
The pleiotropic nature of NONO, a master regulator of essential biological pathways in cancersDomenica Ronchetti, Valentina Traini, Ilaria Silvestris, et al.
Scientific Reports|April 28, 2018
A compendium of long non-coding RNAs transcriptional fingerprint in multiple myelomaDomenica Ronchetti, Luca Agnelli, Alessandro Pietrelli, et al.
Methods in Molecular Biology (Clifton, N.J.)|June 23, 2021
CRISPR Interference (CRISPRi) and CRISPR Activation (CRISPRa) to Explore the Oncogenic lncRNA NetworkEugenio Morelli, Annamaria Gulla', Nicola Amodio, et al.
Haematologica|May 6, 2021
DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcomeKatia Todoerti, Domenica Ronchetti, Vanessa Favasuli, et al.
Cancers|April 3, 2021
The Landscape of Signaling Pathways and Proteasome Inhibitors Combinations in Multiple MyelomaTina Paradzik, Cecilia Bandini, Elisabetta Mereu, et al.
Cancer Letters|May 17, 2015
The BH3-mimetic obatoclax reduces HIF-1α levels and HIF-1 transcriptional activity and sensitizes hypoxic colon adenocarcinoma cells to 5-fluorouracilMarzia B Gariboldi, Elisa Taiana, Maria Chiara Bonzi, et al.
Pageof 4